Despite increased perioperative use of percutaneous ventricular assist devices since 2018, in-hospital mortality for surgical repair of post-infarction ventricular septal defect remains above 30%.
Observational (n=1,763)
Yes
Does the perioperative use of mechanical circulatory support, particularly PVAD, improve in-hospital survival in patients undergoing surgical repair of MI-VSD?
Despite the increasing use of percutaneous ventricular assist devices for MI-VSD, real-world data show no improvement in the persistently high in-hospital mortality rates and an increase in perioperative bleeding.
Ventricular septal defect after myocardial infarction (MI-VSD) is a rare but fatal complication. This real-world database study reports the patient characteristics and outcomes after surgical repair of MI-VSD based on the Japanese Registry of All Cardiac and Vascular Diseases Diagnosis Procedure Combination (JROAD-DPC), especially considering the popularity of percutaneous ventricular assist device (PVAD) use.
Miura et al. (Mon,) conducted a observational in Ventricular septal defect after myocardial infarction (MI-VSD) (n=1,763). Mechanical circulatory support (PVAD, ECMO, IABP) vs. No support or alternative mechanical support was evaluated on In-hospital death. Despite increased perioperative use of percutaneous ventricular assist devices since 2018, in-hospital mortality for surgical repair of post-infarction ventricular septal defect remains above 30%.